| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/2012 | WO2011039511A4 Agents, uses and methods |
| 01/12/2012 | WO2010147412A9 (metha)acrylate polymer, preparation method thereof and oil formulation containing the same |
| 01/12/2012 | WO2009032286A3 Oligomer-calcium channel blocker conjugates |
| 01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010302 New Types of Polyester-Modified Organopolysiloxanes |
| 01/12/2012 | US20120010218 Formulations |
| 01/12/2012 | US20120010133 Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent |
| 01/12/2012 | US20120009272 Compositions and methods for creating an air release mechanism to maintain skin health |
| 01/12/2012 | US20120009267 Nanoparticle compositions and methods for improved oral delivery of active agents |
| 01/12/2012 | US20120009246 Phospholipid-analogous compounds |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009167 Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 01/12/2012 | US20120009132 Transparent Xyloglucan/Chitosan Gel and a Process for the Preparation Thereof |
| 01/12/2012 | DE112009001815T5 Herstellungsverfahren für bioabbaubare Mikropartikel, welche Arzneistoffe enthalten Contain manufacturing method for biodegradable microparticles which drugs |
| 01/12/2012 | CA2840079A1 Compositions and methods for treating influenza |
| 01/12/2012 | CA2805031A1 Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin |
| 01/12/2012 | CA2804926A1 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | CA2804874A1 Formulations comprising coated fine particles |
| 01/12/2012 | CA2804815A1 Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery |
| 01/12/2012 | CA2804686A1 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | CA2804601A1 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 01/12/2012 | CA2804545A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | CA2804504A1 Intraorally disintegrating tablet |
| 01/12/2012 | CA2804477A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 01/12/2012 | CA2804358A1 Pharmaceutical compositions containing vanoxerine |
| 01/12/2012 | CA2804337A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
| 01/12/2012 | CA2804274A1 Factor ix polypeptides and methods of use thereof |
| 01/12/2012 | CA2803004A1 Oral formulation of kinase inhibitors |
| 01/12/2012 | CA2802929A1 Posaconazole intravenous solution formulations stabilized by substituted beta-cyclodextrin |
| 01/12/2012 | CA2801361A1 Resveratrol-containing compositions and methods of use for cardiac related diseases |
| 01/12/2012 | CA2800679A1 Compositions and methods for enhancement of nucleic acid delivery |
| 01/12/2012 | CA2799934A1 Respiratory syncytial virus antigenic compositions and methods |
| 01/12/2012 | CA2791257A1 Guanidinylated aminoglycoside-lipid conjugates |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2405001A1 Nucleic acid complex and nucleic acid-delivering composition |
| 01/11/2012 | EP2404619A1 Injectable composition composed of an injectable medication and a gel |
| 01/11/2012 | EP2404618A1 Immunomodulatory protein constructs with a helical polymeric backbone. |
| 01/11/2012 | EP2404608A1 Combination use of cholestanol derivative |
| 01/11/2012 | EP2404606A1 Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
| 01/11/2012 | EP2404598A1 Amino acid-conjugated cyanoacrylate polymer particles |
| 01/11/2012 | EP2404594A1 Compositions comprising docetaxel with increased stability and methods for preparation thereof |
| 01/11/2012 | EP2403551A2 Silk fibroin systems for antibiotic delivery |
| 01/11/2012 | EP2403539A2 Methods and systems for treatment and/or diagnosis |
| 01/11/2012 | EP2403538A1 Conjugated proteins and peptides |
| 01/11/2012 | EP2403537A1 Interferon alpha carrier prodrugs |
| 01/11/2012 | EP2403536A1 Oral delivery of hydrophilic drugs to the brain |
| 01/11/2012 | EP2403520A1 Insulin formulations for rapid uptake |
| 01/11/2012 | EP2403504A1 Pharmaceutical compositions of active pharmaceutical ingredient comprising sulphonylurea moiety with excellent dissolution properties |
| 01/11/2012 | EP2403493A2 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/11/2012 | EP2403488A2 Controlled-release ophthalmic vehicles |
| 01/11/2012 | EP2403478A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | EP2403477A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | EP2403476A1 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail |
| 01/11/2012 | EP2403447A1 Microencapsulated bioactive agents for oral delivery and methods of use thereof |
| 01/11/2012 | EP2403335A1 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/11/2012 | EP1986696B1 Method for production of a transformed cell |
| 01/11/2012 | EP1946780B1 Controlled release solid preparation |
| 01/11/2012 | EP1891143B1 Polymer-based serum albumin substitute |
| 01/11/2012 | EP1818123B1 Process for producing stabilized gold nanoparticles, stabilized gold nanoparticles obtained by the process, and use of the stabilized gold nanoparticles |
| 01/11/2012 | EP1750703B1 Method for reducing gastrointestinal toxicity due to the administration of tegafur |
| 01/11/2012 | EP1682583B1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/11/2012 | EP1653927B1 Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | EP1191947B1 Methods for treating avm' using radioactive compositions |
| 01/11/2012 | CN202105203U Sticking membrane for dermatosis and ulcer wound surface |
| 01/11/2012 | CN1895222B Production and use for micro-emulsion and its medicine-carrier preparation |
| 01/11/2012 | CN102317435A Equol-producing bacterium and use thereof |
| 01/11/2012 | CN102317305A Functionalising reagents and their uses |
| 01/11/2012 | CN102316902A Glutathione-based drug delivery system |
| 01/11/2012 | CN102316901A Transdermal preparation |
| 01/11/2012 | CN102316874A A disintegrating tablet |
| 01/11/2012 | CN102316860A Film base for adhesive patch, and adhesive patch |
| 01/11/2012 | CN102316857A Misuse preventative, controlled release formulation |
| 01/11/2012 | CN102316856A Pharmaceutical preparation |
| 01/11/2012 | CN102316855A On-demand and reversible drug release by external cue |
| 01/11/2012 | CN102316726A Aqueous dispersion comprising pesticide particles and an amphiphile |
| 01/11/2012 | CN102311512A Cyclodextrin-aliphatic polyester-phosphatidyl ethanolamine graft polymer and preparation method thereof |
| 01/11/2012 | CN102311507A Preparation method of pharmaceutical adjuvant sodium carboxymethyl starch |
| 01/11/2012 | CN102311503A Recombinant human serum albumin / FGF fusion protein with continuous effect on restoration of a plurality of skin cells |
| 01/11/2012 | CN102311501A Fusion protein comprising GLP-1 (Glucagon-Like Peptide) or analog thereof and preparation method as well as application thereof |
| 01/11/2012 | CN102311493A Peptide inhibiting telomerase activity, its preparation method and application |
| 01/11/2012 | CN102311478A Composite lipid comprising cholesterol group and intermediate, preparation method as well as application thereof |
| 01/11/2012 | CN102311454A Compound lipid containing porphyrin ring functional groups, intermediate, preparation method and application thereof |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309766A Method for improving water solubility of xanthohumol |
| 01/11/2012 | CN102309765A Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
| 01/11/2012 | CN102309764A Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 01/11/2012 | CN102309763A Medicinal composition and preparation method thereof |
| 01/11/2012 | CN102309762A Preparation method for lactosaminated carboxymethyl chitosan magnetic nano-particle gene vector |
| 01/11/2012 | CN102309761A Uncharged amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309760A Cationic amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309759A Poultry freeze-drying live vaccine heat-resisting protective agent and preparation method thereof |
| 01/11/2012 | CN102309756A Compound medicament containing phosphodiesterase 4 inhibitor and glucocorticoid and used for treating dermatosis |
| 01/11/2012 | CN102309755A Design scheme for compound type dual duplex locating type intracellular vaccine |
| 01/11/2012 | CN102309739A Chinese medicinal composition dispersible tablets |
| 01/11/2012 | CN102309721A Preparation method of black paste |
| 01/11/2012 | CN102309589A Zuojin gastric-floating tablet and preparation method thereof |
| 01/11/2012 | CN102309579A Tarragon soup effervescent tablet and its preparation method |